Jakura 5mg Tablet

Przegląd produktu

About Jakura

Jakura is a medication containing the active ingredient Tofacitinib, classified as Medication. Tofacitinib, sold under the brand Xeljanz, Neojanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular-course juvenile idiopathic arthritis, and ulcerative colitis.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Tofacitinib extended-release tablets are Janus kinase (JAK) inhibitors
• Used for: Tofacitinib extended-release tablets are indicated for the treatment of adult patients with: Moderately to severely active rheumatoid arthritis (RA).
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Tofacitinib, the active ingredient in Jakura, belongs to the Medication class. 1 INDICATIONS AND USAGE Tofacitinib extended-release tablets are Janus kinase (JAK) inhibitors. Tofacitinib extended-release tablets are indicated for the treatment of adult patients with: Moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response or intolerance to one or more TNF. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Jakura. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Jakura for extended periods without medical advice.